{
    "2018-05-22": [
        [
            {
                "time": "",
                "original_text": "3只医药股创历史新高，8只比药明康德便宜、盈利更强",
                "features": {
                    "keywords": [
                        "医药股",
                        "历史新高",
                        "药明康德",
                        "盈利"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[看好评级] 医药生物行业周报：持续关注绩优龙头和创新药相关企业",
                "features": {
                    "keywords": [
                        "医药生物",
                        "周报",
                        "绩优龙头",
                        "创新药"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "沪指站稳3200，又有利好传来，机构已经行动",
                "features": {
                    "keywords": [
                        "沪指",
                        "3200",
                        "利好",
                        "机构"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物 知识产权保护有望加强 创新药价值提升",
                "features": {
                    "keywords": [
                        "医药生物",
                        "知识产权",
                        "创新药",
                        "价值提升"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报: 持续看好医药板块, 推荐疫苗板块及蓝帆医疗",
                "features": {
                    "keywords": [
                        "医药行业",
                        "周报",
                        "疫苗",
                        "蓝帆医疗"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业: 中长期持续看好板块",
                "features": {
                    "keywords": [
                        "医药生物",
                        "中长期",
                        "看好",
                        "板块"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}